Janus Henderson Group plc 13D and 13G filings for Global Blood Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-10 4:06 pm Sale |
2021-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
JANUS HENDERSON GROUP PLC JHG |
5,483,164 8.500% |
-789,518 (-12.59%) |
Filing |
| 2021-10-12 12:47 pm Purchase |
2021-09-30 | 13G | Global Blood Therapeutics, Inc. GBT |
JANUS HENDERSON GROUP PLC JHG |
6,272,682 10.100% |
305,820 (+5.13%) |
Filing |
| 2021-02-12 3:25 pm Purchase |
2020-12-31 | 13G | Global Blood Therapeutics, Inc. GBT |
JANUS HENDERSON GROUP PLC JHG |
5,966,862 9.700% |
3,443,594 (+136.47%) |
Filing |